These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Orthograde transport and release of insulin-like growth factor I from the inferior olive to the cerebellum. Nieto-Bona MP, Garcia-Segura LM, Torres-Aleman I. J Neurosci Res; 1993 Dec 01; 36(5):520-7. PubMed ID: 7511697 [Abstract] [Full Text] [Related]
65. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. Lochhead JJ, Wolak DJ, Pizzo ME, Thorne RG. J Cereb Blood Flow Metab; 2015 Mar 01; 35(3):371-81. PubMed ID: 25492117 [Abstract] [Full Text] [Related]
67. Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression. Paslakis G, Blum WF, Deuschle M. Med Hypotheses; 2012 Aug 01; 79(2):222-5. PubMed ID: 22626951 [Abstract] [Full Text] [Related]
69. Insulin-like growth factor-II/mannose-6-phosphate receptor: widespread distribution in neurons of the central nervous system including those expressing cholinergic phenotype. Hawkes C, Kar S. J Comp Neurol; 2003 Mar 31; 458(2):113-27. PubMed ID: 12596253 [Abstract] [Full Text] [Related]
71. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Engesser-Cesar C, Anderson AJ, Cotman CW. Neuroscience; 2007 Feb 09; 144(3):1033-44. PubMed ID: 17137724 [Abstract] [Full Text] [Related]
73. Characterization of the acute cardiovascular effects of intravenously administered insulin-like growth factor-I in conscious Sprague-Dawley rats. Cao N, Lau S, Nguyen TT, White PJ. Clin Exp Pharmacol Physiol; 2006 Dec 09; 33(12):1190-5. PubMed ID: 17184500 [Abstract] [Full Text] [Related]